E.sakasaki
-
Upload
abdulrahman-lotfy -
Category
Health & Medicine
-
view
638 -
download
1
Transcript of E.sakasaki
![Page 1: E.sakasaki](https://reader033.fdocuments.us/reader033/viewer/2022042715/559936091a28ab0d178b45cd/html5/thumbnails/1.jpg)
Enterobacter sakazakii
In
Powdere
d Infant
Formula
DR. ABDULRAHMAN LOTFYPreventive Medicine – Jahra Hospital
October 2011
![Page 2: E.sakasaki](https://reader033.fdocuments.us/reader033/viewer/2022042715/559936091a28ab0d178b45cd/html5/thumbnails/2.jpg)
FDA warning to health professionals
powdered infant formula not to be used in neonatal intensive care settings.
![Page 3: E.sakasaki](https://reader033.fdocuments.us/reader033/viewer/2022042715/559936091a28ab0d178b45cd/html5/thumbnails/3.jpg)
Enterobacter sakazakii Opportunistic pathogen that can cause infections
such as necrotizing enterocolitis, bacteraemia, meningitis and brain abscess/lesions.
The species was defined in 1980, by Farmer et al.
![Page 4: E.sakasaki](https://reader033.fdocuments.us/reader033/viewer/2022042715/559936091a28ab0d178b45cd/html5/thumbnails/4.jpg)
Gram-negative straight rod
Enterobacteriaciae family (Coliform bacterium).
the cells are motile (flagellated) and do not form spores.
The Organism
![Page 5: E.sakasaki](https://reader033.fdocuments.us/reader033/viewer/2022042715/559936091a28ab0d178b45cd/html5/thumbnails/5.jpg)
Electron Microscope Photo
web site (http://www.magma.ca/~scimat/E_sakaza.htm).
![Page 6: E.sakasaki](https://reader033.fdocuments.us/reader033/viewer/2022042715/559936091a28ab0d178b45cd/html5/thumbnails/6.jpg)
What is the magnitude of the problem?
The frequency in infants appears to be very low, yet the disease is devastating.
Despite the low frequency of reported infections, mortality rate is relatively high (33%).
SEVERITY
FREQUENCY
![Page 7: E.sakasaki](https://reader033.fdocuments.us/reader033/viewer/2022042715/559936091a28ab0d178b45cd/html5/thumbnails/7.jpg)
Risk FactorsAGE
(3 days to 4 years )
Birth weight
Immunocompromised
• 50% ≤ 1week of age
• 75% < 1 month of age
• 75% Low birth weights ≤ 2.5 kg
• Malignancy
![Page 8: E.sakasaki](https://reader033.fdocuments.us/reader033/viewer/2022042715/559936091a28ab0d178b45cd/html5/thumbnails/8.jpg)
CLINICAL MANIFESTATIONS & Clinical Manifestations Complications:
Reported infection
cases
Meningitis
Brain sepsis
Seizers
Bacteraemia
Ventriculitis (inflammation in the
ventricles of the brain).
Brain cysts and abscesses,
Cerebral infarction,
Hydrocephalus (abnormal increase in
the amount of cerebrospinal fluid within the cranial cavity
Necrotizing enterocolitis (localized
death of small and large intestine tissues).
Death may occur within a few hours to several days.
![Page 9: E.sakasaki](https://reader033.fdocuments.us/reader033/viewer/2022042715/559936091a28ab0d178b45cd/html5/thumbnails/9.jpg)
Mortality Rate:
50%• premature
• Low BW
30%• Full term
• Normal BW
![Page 10: E.sakasaki](https://reader033.fdocuments.us/reader033/viewer/2022042715/559936091a28ab0d178b45cd/html5/thumbnails/10.jpg)
Fatality From Meningitis*
62%
14%
Before use of cephalosporines
After use of cephalosporines
*Only one death has been reported in the absence of meningitis, a neonate exhibiting bacteremia.
![Page 11: E.sakasaki](https://reader033.fdocuments.us/reader033/viewer/2022042715/559936091a28ab0d178b45cd/html5/thumbnails/11.jpg)
Antibiotic Susceptibility of E. sakazakii
Susceptibility Resistence Ampicillin,
Tetracycline,
Chloramphenicol,
Gentamicin, and
third-generation cephalosporins.
aminoglycosides :Although E. sakazakii isolates are typically
susceptible to it , such antibiotics are not recommended for primary treatment because of poor penetration into the central nervous system.
Cefazolin, and
extended-spectrum penicillins.
![Page 12: E.sakasaki](https://reader033.fdocuments.us/reader033/viewer/2022042715/559936091a28ab0d178b45cd/html5/thumbnails/12.jpg)
Treatment
After 1985
3rd generation cephalosporines
Ampicillin Gentamycin
Before 1985
Ampicillin GentamycinAnd/or
Chloramphenicol
![Page 13: E.sakasaki](https://reader033.fdocuments.us/reader033/viewer/2022042715/559936091a28ab0d178b45cd/html5/thumbnails/13.jpg)
Sporadic cases and outbreaks of Enterobacter sakazakii infection for which powdered infant
formula (PIF) was implicated as the source agent.
Drudy D et al. Clin Infect Dis. 2006;42:996-1002
© 2006 by the Infectious Diseases Society of America
![Page 14: E.sakasaki](https://reader033.fdocuments.us/reader033/viewer/2022042715/559936091a28ab0d178b45cd/html5/thumbnails/14.jpg)
Is the risk similar in all regions and countries?
Under
reporting
Lack of Awareness
Limitation of current
surveillance
Reporting only in a few developed
countries
![Page 15: E.sakasaki](https://reader033.fdocuments.us/reader033/viewer/2022042715/559936091a28ab0d178b45cd/html5/thumbnails/15.jpg)
A significant public health problem
IF is widely used
the presence of E.s. in infant formula
The potential effect in infants
![Page 16: E.sakasaki](https://reader033.fdocuments.us/reader033/viewer/2022042715/559936091a28ab0d178b45cd/html5/thumbnails/16.jpg)
Source of E. sakazakii Infections In early cases of E. sakazakii infections, an environmental
source of the organism could not be identified
Vertical transmission is not documented.
Dried infant formula, has been identified epidemiologically as the source of E. sakazakii in three outbreaks of neonatal meningitis and linked to one outbreak of necrotizing enterocolitis.
![Page 17: E.sakasaki](https://reader033.fdocuments.us/reader033/viewer/2022042715/559936091a28ab0d178b45cd/html5/thumbnails/17.jpg)
Ecology of E. sakazakiiFlies( Fruit Flies, Stable)
Dust
Rodents & bird dung
Surface water & Soil
domestic animals, cattle and raw cow’s milk
Mud & rotting wood
Food
![Page 18: E.sakasaki](https://reader033.fdocuments.us/reader033/viewer/2022042715/559936091a28ab0d178b45cd/html5/thumbnails/18.jpg)
E. Sakazakii and flies household flies, were found to carry E. sakazakii.
Similarly, E. sakazakii has been isolated from the gut flora of fruit flies, with no differences in distribution between males and females. Surprisingly, the organism was only isolated from a culture of fruit flies propagated in 1998 and not from a colony of flies over 30 years old.
![Page 19: E.sakasaki](https://reader033.fdocuments.us/reader033/viewer/2022042715/559936091a28ab0d178b45cd/html5/thumbnails/19.jpg)
Foods from which the organism has been isolated
Meat & minced beef,
Sausages
Vegetables,(Lettuce, alfalfa sprouts)
Tofu;
Bread,
Cheese;
Rice seed
•Herbs & spices
•Sous (licorice drink)
•Dried products (infant cereal,, spices, whey, egg yolk , flour/meal)
![Page 20: E.sakasaki](https://reader033.fdocuments.us/reader033/viewer/2022042715/559936091a28ab0d178b45cd/html5/thumbnails/20.jpg)
Occurrence in food production environments and households
![Page 21: E.sakasaki](https://reader033.fdocuments.us/reader033/viewer/2022042715/559936091a28ab0d178b45cd/html5/thumbnails/21.jpg)
PIF and E. sakazakii
Powdered milk substitute infant formulas are the principal sources from which E. sakazakii has been isolated.
![Page 22: E.sakasaki](https://reader033.fdocuments.us/reader033/viewer/2022042715/559936091a28ab0d178b45cd/html5/thumbnails/22.jpg)
WHO – NO E.s. in BF. In the current state of
knowledge, no exclusively BF infants have been reported to have Enterobacter sakazakii infections.
Based on the available information, in 50-80 % of cases, PIF is both the vehicle and the source (direct or indirect) of E. sakazakii induced illness.
BF IF
![Page 23: E.sakasaki](https://reader033.fdocuments.us/reader033/viewer/2022042715/559936091a28ab0d178b45cd/html5/thumbnails/23.jpg)
Survey - 1988 E . sakazakii was isolated from 20 of 141 dried infant
formulas from 35 countries in a 1988 survey
![Page 24: E.sakasaki](https://reader033.fdocuments.us/reader033/viewer/2022042715/559936091a28ab0d178b45cd/html5/thumbnails/24.jpg)
latest study ( 2008 published 2010) In 2008 a study was done
in Japan showed that E.sakazakii isolated in 6% of PIF samples suggesting that commercially available PIF products can be contaminated with this type of bacteria
![Page 25: E.sakasaki](https://reader033.fdocuments.us/reader033/viewer/2022042715/559936091a28ab0d178b45cd/html5/thumbnails/25.jpg)
![Page 26: E.sakasaki](https://reader033.fdocuments.us/reader033/viewer/2022042715/559936091a28ab0d178b45cd/html5/thumbnails/26.jpg)
How does infant formula get contaminated with Enterobacter sakazakii?
Basically there are three routes by which Enterobacter sakazakii can enter infant formula:
![Page 27: E.sakasaki](https://reader033.fdocuments.us/reader033/viewer/2022042715/559936091a28ab0d178b45cd/html5/thumbnails/27.jpg)
1. Raw material used for producing the formula;
2. Contamination of the formula or other dry ingredients after pasteurization
3. Contamination of the formula as it is being reconstituted by the caregiver just prior to feeding.
![Page 28: E.sakasaki](https://reader033.fdocuments.us/reader033/viewer/2022042715/559936091a28ab0d178b45cd/html5/thumbnails/28.jpg)
colony-forming unit (CFU )is a measure of viable bacterial or fungal numbers. Unlike direct microscopic counts where all cells, dead and living, are counted, CFU measures viable cells. For convenience the results are given as CFU/mL (colony-forming units per milliliter) for liquids, and CFU/g (colony-forming units per gram) for solids.
![Page 29: E.sakasaki](https://reader033.fdocuments.us/reader033/viewer/2022042715/559936091a28ab0d178b45cd/html5/thumbnails/29.jpg)
![Page 30: E.sakasaki](https://reader033.fdocuments.us/reader033/viewer/2022042715/559936091a28ab0d178b45cd/html5/thumbnails/30.jpg)
![Page 31: E.sakasaki](https://reader033.fdocuments.us/reader033/viewer/2022042715/559936091a28ab0d178b45cd/html5/thumbnails/31.jpg)
Current Regulations Affecting Occurrence of E. sakazakii in Powdered Infant Formulas
Regulations governing the prevalence of E. sakazakii in powdered infant formulas falls under the hygienic requirements for allowable levels of coliforms.
For the Codex Alimentarius, these requirements include: minimum of four of five control samples with < 3 coliforms/g and
a maximum of one of five control samples with >3 but ≤ 20 coliforms/g.
Based upon these test parameters, dry milk-based infant formula that contains E.sakazakii at levels of < 1 organism per 100 g of formula would not be reliably detected.
![Page 32: E.sakasaki](https://reader033.fdocuments.us/reader033/viewer/2022042715/559936091a28ab0d178b45cd/html5/thumbnails/32.jpg)
What do we
do now??
![Page 33: E.sakasaki](https://reader033.fdocuments.us/reader033/viewer/2022042715/559936091a28ab0d178b45cd/html5/thumbnails/33.jpg)
Recommendations & Preventative Strategies The promotion of
breast milk feeding,
The World Health Organization recommends that infants should be exclusively breast-fed for the first 6 months of life.
Infants who are not breast-fed should be provided with a suitable breast milk substitute, formulated in accordance with Codex Alimentarius Commission standards.
To reduce the risk of infection in infants fed PIF, recommendations have been made for the preparation and storage of PIF
![Page 34: E.sakasaki](https://reader033.fdocuments.us/reader033/viewer/2022042715/559936091a28ab0d178b45cd/html5/thumbnails/34.jpg)
Inclusion of warnings on powdered infant formula packages that they may be contaminated with ES.
![Page 35: E.sakasaki](https://reader033.fdocuments.us/reader033/viewer/2022042715/559936091a28ab0d178b45cd/html5/thumbnails/35.jpg)
Education:
The ideal practice of re-warming of reconstituted formula.
Better understanding of the progression and pathogenesis ES related diseases
![Page 36: E.sakasaki](https://reader033.fdocuments.us/reader033/viewer/2022042715/559936091a28ab0d178b45cd/html5/thumbnails/36.jpg)
Why education?
Many individuals unaware that PIF is not a sterile product
Lack information on how handling, storage and preparation practices can influence the risk
Effective risk communication practices needed for the public and health professionals
![Page 37: E.sakasaki](https://reader033.fdocuments.us/reader033/viewer/2022042715/559936091a28ab0d178b45cd/html5/thumbnails/37.jpg)
Summary & Conclusion E. sakazakii is a pathogenic microorganism
The precise pathogenesis of ES remains a mystery.
Natural habitat is not known yet
Found in infant formula
Thermo-tolerant
FDA recommend method need some improvement
There are much more work to be done…….
Appropriate measures by parents, infant formula manufacturers, and health care providers, as well as understanding of the pathogenesis, are important in the prevention.
![Page 38: E.sakasaki](https://reader033.fdocuments.us/reader033/viewer/2022042715/559936091a28ab0d178b45cd/html5/thumbnails/38.jpg)